CLINICAL_TRIALS
research
· 2025-12-02
Clinical Trial Update: Modified Conditioning Regimen for CML-BP [Phase 2]
Summary
A Phase 2 clinical trial is evaluating a modified conditioning regimen for chronic myeloid leukemia in blast phase patients undergoing hematopoietic stem cell t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: CML,Blast Phase, HSCT | Phase 2 | Status: NOT_YET_RECRUITING